OpenVSafe by OpenVAERS
Search V-safe

DS8-14999-27528

2 vaccinations 8 coded responses 23 check-ins 8 free-text entries 3 call cases
Sex
Female
Age at first dose
61-65
ZIP prefix
121 / NY
Registered
2021-01-23
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-21
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-23
    Registered in v-safe
  3. 2021-01-23
    Survey response — days 1–6 daily, dose 1
    MedDRA: Feeling abnormal, Headache, Self-medication — Feeling: Good · Site: Pain · Joint pains
    Free text: 6 hours post vaccine had mild headache with brain fog - headache resolved with pain reliever; brain fog persisted approximately 36 hours
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-01-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-28
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-05
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-02-11
    Dose 2 — Pfizer-BioNTech
  11. 2021-02-11
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  12. 2021-02-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  13. 2021-02-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fever · Chills, Joint pains, Fatigue or tiredness
    Adult check-in
  14. 2021-02-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Tenderness — Feeling: Fair · Site: Pain · Be unable to do your normal daily activities
    Free text: Constant tenderness over left temple
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-02-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Headache, Hypoaesthesia, Hypoaesthesia eye — Feeling: Fair · Site: Pain · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Pain left temple, superficial numbness on left side of face - cheek and around eye
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-02-15
    Report sent to call center — days 1–6 daily, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  17. 2021-02-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Headache, Hypoaesthesia — Feeling: Good · Site: Pain · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Temple pain and facial numbness are resolving with Providers recommendations
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-02-16
    Report sent to call center — days 1–6 daily, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  19. 2021-02-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  20. 2021-02-18
    Health check-in — day 7, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  21. 2021-02-25
    Survey response — day 14, dose 2
    MedDRA: Laboratory test abnormal, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Thyroid testing resulted as abnormal - tested as a result of symptom onset 3 days post vaccine. · Healthcare visit (other): Laboratory draw
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-02-25
    Report sent to call center — day 14, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  23. 2021-03-04
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-11
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-03-18
    Survey response — day 35, dose 2
    MedDRA: Hypoaesthesia — Feeling: Good
    Free text: Facial numbness which varies in severity, ongoing, intermittent discussion with MD - essentially awaiting resolution.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-03-25
    Survey response — day 42, dose 2
    MedDRA: Hypoaesthesia, Thyroid disorder — Feeling: Good
    Free text: Intermittent facial numbness continues to be an issue. Awaiting followup lab work for thyroid issues
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-05-13
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-08-04
  29. 2021-08-12
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  30. 2022-02-11
    Survey response — 12 months, dose 2
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good
    Free text: Slight exacerbation of facial numbness after booster. Mild numbness has been persistent but better.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-01-21Pfizer-BioNTech
22021-02-11Pfizer-BioNTech

Call center

3 call center cases

3 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-23

Systemic reaction (other): 6 hours post vaccine had mild headache with brain fog - headache resolved with pain reliever; brain fog persisted approximately 36 hours

Release 4 — days 1–6 daily, dose 2

2021-02-14

Systemic reaction (other): Constant tenderness over left temple

2021-02-15

Systemic reaction (other): Pain left temple, superficial numbness on left side of face - cheek and around eye

2021-02-16

Systemic reaction (other): Temple pain and facial numbness are resolving with Providers recommendations

Release 4 — day 14, dose 2

2021-02-25

Symptoms: Thyroid testing resulted as abnormal - tested as a result of symptom onset 3 days post vaccine.
Healthcare visit (other): Laboratory draw

Release 5 — day 35, dose 2

2021-03-18

Symptoms: Facial numbness which varies in severity, ongoing, intermittent discussion with MD - essentially awaiting resolution.

Release 6 — day 42, dose 2

2021-03-25

Symptoms: Intermittent facial numbness continues to be an issue. Awaiting followup lab work for thyroid issues

Release 11 — 12 months, dose 2

2022-02-11

Symptoms: Slight exacerbation of facial numbness after booster. Mild numbness has been persistent but better.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event ✓ ✓ ✓
SDCondition aggravated · · ✓
SDHypoaesthesia ✓ ✓ ✓
SDLaboratory test abnormal ✓ ✓ ✓
SDPre-existing disease · · ✓
SDThyroid disorder ✓ ✓ ✓
SROFeeling abnormal ✓ ✓ ✓
SROHeadache ✓ ✓ ✓
SROHypoaesthesia ✓ ✓ ✓
SROHypoaesthesia eye ✓ ✓ ✓
SROSelf-medication ✓ ✓ ✓
SROTenderness ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release